Regulation of cyclooxygenase-2 expression by the WNT and ras pathways

Cancer Research

Volumn 63, Issue 3, 2003, Pages 728-734

  Araki, Yuzuru ^a   Okamura, Shu ^a   Hussain, S Perwez ^a   Nagashima, Makoto ^b   He, Peijun ^a   Shiseki, Masayuki ^a   Miura, Koh ^a   Harris, Curtis C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLOOXYGENASE 2; LUCIFERASE; PROTEIN; RAS PROTEIN; T CELL FACTOR 4; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; ONCOGENE K RAS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; ISOENZYMES; LUCIFERASES; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037310126     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Smith, W. L., Garavito, R. M., and DeWitt, D. L. Prostaglandin endoperoxide H synthases (Cyclooxygenases)-1 and -2. J Biol. Chem., 271: 33157-33160, 1996.
2. Turini, M. E., and DuBois, R. N. Cyclooxygenase-2: A therapeutic target. Annu. Rev. Med., 53: 35-57, 2002.
3. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56: 733-737, 1996.
4. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83: 493-501, 1995.
5. Gupta, R. A., and DuBois, R. N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Reviews Cancer. 1: 11-21, 2001.
6. Δ7166knockout mice by inhibition of cyclooxygenase 2(COX-2). Cell. 87: 803-809, 1996.
7. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, R., and Offerhaus, J. A. Treatment of colonic and rectal adenomas with sulindac in familial adenoatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
8. Nakamura. Y. The role of the adenomatous polyposis coli (APC) gene in human cancers. Adv. Cancer Res., 62: 65-87. 1993.
9. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
10. Taverso, G., Shuber, A., Levin, B., Johnson, C., Olsson, L., Schoetz, D. J., Hamilton, S. R., Boynton, K., Kinzler, K. W., and Vogelstein, B. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med., 346: 311-320, 2002.
11. Bienz, M., and Clevers, H. Linking colorectal cancer to Wnt signaling. Cell. 103: 311-320, 2000.
12. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., and Polakis, P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science (Wash. DC), 272: 1023-1026, 1996.
13. Ikeda, S., Kishida, S., Yamamoto, H., Mural, H., Koyama, S., and Kikuchi, A. Axin, a negative regulator of the Wnt-signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J., 17: 1371-1384, 1988.
14. Shih, I-M., Yu, J., He, T-C., Vogelstein, B., and Kinzler, K. W. The β-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res., 60: 1671-1676, 2000.
15. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382: 638-642, 1996.
16. He T-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler. K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
17. Tetsu, O., and McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
18. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., and D'Amico, M., Pestell, R., and Ben-Ze'ev, A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 96: 5522-5527, 1999.
19. He, T-C., Chan, T. A., Vogelstein, B., and Kinzler, K. W. PPAR δ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell, 99: 335-345, 1999.
20. Cadigan, K. M., and Nusse, R. Wnt signaling: a common theme in animal development. Genes Dev., 11: 3286-3305, 1997.
21. Dale T. C., Signal transduction by the Wnt family of ligands. Biochem. J., 329: 209-223, 1998.
22. Mei, J. M., Hord, N. G., Winterstein, D. F., Donald, S. P., and Phang, J. M. Differential expression of prostaglandin endoperoxide H synthase-2 and formatβ-catenin-LEF-1 transcription of activated-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc. Carcinogenesis (Lond.), 20: 737-740, 1999.
23. Howe, L. R., Subbaramaiah, K., Chung, W. J., Dannenberg, A. J., and Brown, M. C. A. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res., 59: 1572-1577, 1999.
24. Dempke, W., Rie, C., Grothey A., and Schmoll H-J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol., 127: 411-417, 2001.
25. Prescott, S. M., and White, R. L. Self-promotion?. Intimate connections between APC and prostaglandin H synthase-2. Cell, 87: 783-786, 1996.
26. Sheng, H., Williams, C. S., Shao, J., Liang, P., and DuBois, R. N. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem., 273: 22120-22127, 1998.
27. Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., and Beauchamp, R. D. Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem., 275: 6628-6635, 2000.
28. Sheng, H., Shao, J., and DuBois, R. N. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B. Cancer Res., 61: 2670-2675, 2001.
29. Morin, P. J., Vogelstein, B., and Kinzler, K. W. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci, USA, 93: 7950-7954, 1996.
30. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Investig., 99: 2254-2259, 1997.
31. Inoue, H., Nanayama, T., Hara, S., Yokoyama, C., and Tanabe, T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandinendopreoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett., 359: 51-54, 1994.
32. 1- colon carcionoma. Science (Wash. DC), 275: 1784-1787, 1997.
33. Pruitt. K., Pestell, R. G., and Der, C. J. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. J. Biol. Chem., 275: 40916-40924, 2000.
34. Dixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A., and Prescott. S. M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Investig., 108: 1657-1665, 2001.
35. Baulida, J., Battle, E., and de Herreros, A. G. Adenomatous polyposis coli protein (APC)-independent regulation of β-catenin/Tcf-4-mediated transcription in intestinal cells. Biochem. J., 344: 565-570, 1999.
36. Shao, J., Sheng, H., Inoue, H., Morrow. J. D., and DuBois, R. N. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275: 33951-33956, 2000.
37. Kutchera, W., Jones, D. A., Matsunami, N., Grodden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
38. His, L. C., Angerman-Steward, J., and Eling, T. E. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis (Lond.), 20: 2045-2049, 1999.
39. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., C evers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling it colon cancer by mutations in β-catenin or APC. Science (Wash. DC), 275: 1787-1790, 1997.
40. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N, Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. AXINI mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXINI. Nat. Genet., 24: 245-250, 2000.
41. Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. Post-transcriptional control of cyclooxygenase-2 gene expression: The role of the 3′-untranslated region. J. Biol. Chem., 275: 11750-11757, 2000.
42. Zhang, Z., Sheng, H., Shao, J., Beauchamp, R. D., and DuBois, R. N. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia, 2: 523-530, 2000.
43. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
44. Sheng H., Shao J., Washington K., and DuBois R. N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276: 18075-18081. 2001.
45. Howe, L. R., Crawford, H. C., Subbaramaiah. K., Hassell, J. A., Dannenberg, A. J., and Brown, A. M. C. PEA3 is up-regulated in response to Wntl and activates the expression of cyclooxygenase-2. J. Biol. Chem., 276: 20108-20115, 2001.
46. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998.
47. Ilyas, M., Tomlinson, I. P. M., Rowan, A., Pignatelli, M., and Bodmer, W. F. β-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 10330-10334, 1997.
48. Iwamoto, M., Ahnen, D. J., Franklin, W. A., and Maltman, T. H. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis (Lond.), 21: 1935-1940, 2000.
49. Kobayashi, M., Honma, T., Matsuda, Y., Suzuki, Y., Naisawa, R., Ajioka, Y., and Asakura, H. Nuclear translocation of β-catenin in colorectal cancer. Br. J. Cancer, 82: 1689-1693, 2000.
50. Takahashi, M., Mutoh, M., Kawamori, T., Sugimura, T., and Wakabayashi, K. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis (Lond.), 21: 1319-1327, 2000.
51. Ozturk, M. Genetic aspects of hepatocellular carcinogenesis. Sem. Liver Dis., 19: 235-242, 1999.
52. Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., and Ohgaki, H. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 155: 1795-1801, 1999.
53. Shiota, G., Okubo, M., Noumi, T., Noguchi, N., Oyama, K., Takano, Y., Yashima, K., Kishimoto, Y., and Kawasaki, H. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology, 46: 407-412, 1999.
54. DuBois, R. N. Cyclooxygenase-2 and hepatocellular carcinoma: is it a target for prevention? Clin. Cancer Res., 7: 1110-1111. 2001.
55. Scharf, J-G., Dombrowski, F., and Ramadori, G. The IGF axis and hepatocarcinogenesis. J. Clin Pathol. Mol. Pathol., 54: 138-144, 2001.
56. Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoel. M. J., Bertrand, F., Cherqui, G., Perret, C., and Capeau, J. Insulin and IGF-1 stimulate the β-catenin pathway through two signaling cascades involving GSK-3β inhibition and Ras activation. Oncogene, 20: 252-259, 2001.